James Helliwell
Vermogen: 7 M $ op 31-07-2026
Vermogen: 7 M $ op 31-07-2026
James A. Helliwell is the founder of Eupraxia Pharmaceuticals, Inc., founded in 2011, where Dr. Helliwell holds the titles of Chief Executive Officer & Director.
Dr. Helliwell is also the founder of Accuro Technologies, Inc...
Dr. Helliwell is currently the Chairman at Guidestar Medical Devices.
Formerly, Dr. Helliwell was an Assistant Professor at the University of British Columbia.
Dr. Helliwell completed undergraduate education at the University of British Columbia.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 1.055.012 ( 1,61% ) | 7 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Oprichter | 12-05-2011 |
Guidestar Medical Devices
Guidestar Medical Devices Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Voorzitter | - |
Accuro Technologies, Inc. | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accuro Technologies, Inc. | |
Guidestar Medical Devices
Guidestar Medical Devices Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau